BIOLOGY TO BARCODES Trademark

Trademark Overview


On Monday, December 7, 2020, a trademark application was filed for BIOLOGY TO BARCODES with the United States Patent and Trademark Office. The USPTO has given the BIOLOGY TO BARCODES trademark a serial number of 90364536. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, August 1, 2024. This trademark is owned by BioSpyder Technologies, Inc.. The BIOLOGY TO BARCODES trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diag...

DNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnosis and treatment of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnosis of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic testing, monitoring and reporting services; Medical dosimetry services for treating radiation exposure; Medical screening; Medical screening services in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery dise...

Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Filters for blood and blood components for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus for detecting cancer; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditions, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical device and surgic...
biology to barcodes

General Information


Serial Number90364536
Word MarkBIOLOGY TO BARCODES
Filing DateMonday, December 7, 2020
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Goods and ServicesChemical reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzymes for medical purposes; Enzymes for veterinary purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, water analysis, and liquid biopsy; Nucleic acid sequences and chemical reagents for medical and veterinary purposes
Pseudo MarkBIOLOGY TO BAR CODES
Goods and ServicesDNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnosis and treatment of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnosis of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic testing, monitoring and reporting services; Medical dosimetry services for treating radiation exposure; Medical screening; Medical screening services in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing of urine, blood, hair follicles and breath; Providing cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing information in the field of diabetes; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals
Goods and ServicesBlood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Filters for blood and blood components for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus for detecting cancer; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditions, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for detecting cancer; Medical devices for dosimetry purposes in the field of radiotherapy; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways, sold as a unit; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing the presence of nucleic acids and antigens, and modifications thereof, gene expression, tissue structures, radiation exposure; Medical diagnostic apparatus for testing biological samples,  DNA, RNA, proteins, viruses, single cells, tissue, organs, biochemical preparations, and waste water incorporating recorded operating system software; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria; Medical instruments for analyzing and identifying bacteria; Medical instruments for use in treating cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical instruments, namely, biosensors for detecting infectious diseases; Medical specimen collection devices in the nature of bottles, tubes, swabs, syringes, and wipes for the collection of nasal mucus, respiratory droplets, saliva, blood, urine, and feces; Sample preparation device for medical diagnostic uses

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateTuesday, March 30, 2021
First Use In Commerce DateTuesday, March 30, 2021

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code010
First Use Anywhere DateTuesday, March 30, 2021
First Use In Commerce DateTuesday, March 30, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code044
First Use Anywhere DateTuesday, March 30, 2021
First Use In Commerce DateTuesday, March 30, 2021

Trademark Owner History


Party NameBioSpyder Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Party NameBioSpyder Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92008

Trademark Events


Event DateEvent Description
Thursday, December 10, 2020NEW APPLICATION ENTERED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 26, 2021ASSIGNED TO EXAMINER
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 3, 2022SOU EXTENSION 1 FILED
Thursday, February 3, 2022SOU EXTENSION 1 GRANTED
Saturday, February 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022SOU EXTENSION 2 FILED
Friday, July 29, 2022SOU EXTENSION 2 GRANTED
Tuesday, August 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023SOU EXTENSION 3 FILED
Tuesday, January 31, 2023SOU EXTENSION 3 GRANTED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 4 FILED
Thursday, August 3, 2023SOU EXTENSION 4 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, January 24, 2024USE AMENDMENT FILED
Wednesday, February 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 15, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, October 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED